Form 4 for ASTH Astrana Health, Inc.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-08 · accession 0001104659-24-116858 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-12 | 2024-11-08 | ASTH | Sim Brandon | CEO, Pres | A - Grant | $0.00 | +34.4K | 983.4K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-08 | A | A | 34,386 | $0.00 | 983,372 | D | — | — | (F3) Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal installments, with the first installment vesting on November 8, 2024, and the remaining shares vesting in seven equal semi-annual installments beginning on April 2, 2025. (F4) Includes 497,999 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 54,280 shares, which will vest in two equal annual installments on June 27, 2025 and 2026; (ii) 5,557 shares, which will vest in two equal annual installments on June 27, 2025 and 2026; (iii) 85,513 shares, which will vest in five equal semi-annual installments, beginning March 31, 2025; and (iv) grants of 99,255 shares, 10,160 shares and 243,234 shares, each of which will vest upon achievement of certain pre-established performance goals. Also includes 105,605 restricted stock units, which will vest in seven equal semi-annual installments beginning on April 2, 2025 (subject to continuous employment with the Issuer). (F5) Includes 644 shares acquired under the Issuer's Employee Stock Purchase Plan. |